Gianni Marone Selected Research

Vascular Endothelial Growth Factors

6/2020	Angiopoietins, Vascular Endothelial Growth Factors and Secretory Phospholipase A2 in Ischemic and Non-Ischemic Heart Failure.
1/2018	Innate effector cells in angiogenesis and lymphangiogenesis.
5/2010	Production of vascular endothelial growth factors from human lung macrophages induced by group IIA and group X secreted phospholipases A2.
11/2006	Expression and functions of the vascular endothelial growth factors and their receptors in human basophils.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianni Marone Research Topics

Disease

19	Inflammation (Inflammations) 01/2022 - 03/2003
19	Neoplasms (Cancer) 12/2021 - 05/2010
11	Asthma (Bronchial Asthma) 04/2022 - 03/2003
5	Hypersensitivity (Allergy) 04/2022 - 07/2003
4	Autoimmune Diseases (Autoimmune Disease) 01/2016 - 07/2003
4	Anaphylaxis (Anaphylactic Shock) 01/2014 - 01/2004
3	Cardiotoxicity 11/2019 - 01/2017
3	Rheumatoid Arthritis 12/2018 - 01/2002
3	Hereditary Angioedemas 01/2018 - 03/2014
3	Hepatitis 01/2007 - 12/2003
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2007
2	Atopic Dermatitis (Atopic Eczema) 01/2022 - 01/2007
2	Chronic Urticaria 01/2022 - 01/2007
2	Pneumonia (Pneumonitis) 01/2022 - 11/2011
2	Common Variable Immunodeficiency 01/2021 - 01/2011
2	Systemic Scleroderma (Systemic Sclerosis) 06/2020 - 01/2018
2	Lung Diseases (Lung Disease) 05/2020 - 05/2010
2	Fibrosis (Cirrhosis) 11/2019 - 06/2015
2	Arthritis (Polyarthritis) 12/2018 - 09/2015
2	Churg-Strauss Syndrome (Allergic Angiitis) 01/2017 - 01/2016
2	Eosinophilia 01/2016 - 03/2003
2	Rhinitis 06/2010 - 07/2003
1	Thyroid Neoplasms (Thyroid Cancer) 01/2022
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2022
1	Heart Diseases (Heart Disease) 01/2021
1	Pulmonary Hypertension 06/2020
1	Pulmonary Arterial Hypertension 06/2020
1	Right Ventricular Dysfunction 06/2020
1	Heart Failure 06/2020
1	Lymphoma (Lymphomas) 11/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 11/2019
1	Hypophysitis 05/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 05/2019
1	Stomach Neoplasms (Stomach Cancer) 04/2019
1	Melanoma (Melanoma, Malignant) 02/2019

Drug/Important Bio-Agent (IBA)

14	CytokinesIBA 01/2022 - 07/2003
12	Immunoglobulin E (IgE)IBA 01/2022 - 01/2004
9	Secretory Phospholipases A2IBA 06/2020 - 03/2003
6	Proteins (Proteins, Gene)FDA Link 02/2019 - 12/2003
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 11/2006
5	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2017
4	Protein Isoforms (Isoforms)IBA 01/2021 - 06/2010
4	LigandsIBA 01/2021 - 01/2017
4	Monoclonal AntibodiesIBA 01/2021 - 01/2017
4	Vascular Endothelial Growth FactorsIBA 06/2020 - 11/2006
4	Biological ProductsIBA 01/2018 - 12/2003
3	Immunoglobulins (Immunoglobulin)IBA 04/2022 - 12/2003
3	AntigensIBA 09/2019 - 08/2009
3	ChemokinesIBA 09/2019 - 07/2003
3	AnaphylatoxinsIBA 01/2014 - 01/2004
3	Contrast MediaIBA 01/2014 - 01/2004
3	Protamines (Protamine Sulfate)FDA Link 01/2014 - 01/2004
3	SuperantigensIBA 08/2009 - 12/2003
2	Immunoglobulin A (IgA)IBA 04/2022 - 01/2021
2	AlarminsIBA 01/2022 - 01/2018
2	AutoantibodiesIBA 01/2022 - 12/2018
2	anti-IgE antibodiesIBA 01/2022 - 01/2020
2	Immunoglobulin G (IgG)IBA 01/2022 - 01/2021
2	AngiopoietinsIBA 01/2022 - 06/2020
2	Vascular Endothelial Growth Factor CIBA 01/2022 - 04/2019
2	Interleukin-3 (Interleukin 3)IBA 01/2021 - 01/2016
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2021 - 04/2016
2	AnthracyclinesIBA 11/2019 - 01/2017
2	Antineoplastic Agents (Antineoplastics)IBA 11/2019 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 02/2019 - 01/2016
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Interleukin-33IBA 01/2018 - 09/2015
2	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2018 - 12/2015
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2018 - 10/2003
2	Omalizumab (Xolair)FDA Link 01/2017 - 01/2016
2	Complement System Proteins (Complement)IBA 01/2014 - 01/2010
2	General AnestheticsIBA 01/2014 - 01/2010
2	Phospholipases AIBA 05/2010 - 03/2003
2	AllergensIBA 07/2007 - 01/2007
1	SmokeIBA 01/2022
1	CannabinoidsIBA 01/2021
1	EndocannabinoidsIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	Vasodilator Agents (Vasodilators)IBA 06/2020
1	Calcimycin (A23187)IBA 01/2020
1	leucyl-phenylalanineIBA 01/2020
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2020
1	IonophoresIBA 01/2020
1	AdipokinesIBA 09/2019
1	IpilimumabIBA 05/2019
1	avelumabIBA 05/2019
1	atezolizumabIBA 05/2019
1	NivolumabIBA 05/2019
1	Gonadal HormonesIBA 05/2019
1	pembrolizumabIBA 05/2019
1	Insulin (Novolin)FDA Link 05/2019
1	PeriostinIBA 01/2019

Therapy/Procedure

12	Therapeutics 04/2022 - 10/2004
5	Immunotherapy 09/2019 - 01/2016
1	Precision Medicine 04/2022
1	Ligation 01/2020
1	Drug Therapy (Chemotherapy) 11/2019
1	Aftercare (After-Treatment) 11/2019
1	Radiotherapy 11/2019
1	Biological Therapy 01/2019